Fig. 2
From: Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases
Changes in the scores of objective clinical signs after initiation of tacrolimus eye drop treatment. The total score of the 10 clinical signs (range 0–30) significantly decreased from baseline to 2 weeks after initiation of tacrolimus eye drop treatment. Tacrolimus eye drops elicited a statistically significant difference in the mean total clinical scores over the course of treatment. The adjusted mean score was 14.3 (95% CI, 12.1–16.6) at baseline and decreased to 3.49 (95% CI, 0.88–6.11) at 10 years after initiation